Kathryn J Aikin1, Kevin R Betts2, Vanessa Boudewyns3, Mihaela Johnson4, Christine N Davis5. 1. US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Prescription Drug Promotion, 10903 New Hampshire Ave., Silver Spring, MD, 20993, USA. Electronic address: kathryn.aikin@fda.hhs.gov. 2. US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Prescription Drug Promotion, 10903 New Hampshire Ave., Silver Spring, MD, 20993, USA. Electronic address: kevin.betts@fda.hhs.gov. 3. RTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC, 27709, USA. Electronic address: vboudewyns@rti.org. 4. RTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC, 27709, USA. Electronic address: mjohnson@rti.org. 5. RTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC, 27709, USA. Electronic address: cdavis@rti.org.
Abstract
BACKGROUND: Research on the major risk statement in direct-to-consumer (DTC) prescription drug television ads has shown that risk severity and actionability can affect consumers' risk comprehension and perceptions. A framing statement presented just before the major risk statement may serve as a cue that directs attention to the risk statement that follows, or it may guide consumers' interpretation of the severity of the risks that follow. OBJECTIVE: Examine how the use of different framing statements (severe, life-threatening; serious; or basic) that precede the major risk statement in DTC television ads affect consumers' risk perceptions, risk recognition, benefit perceptions, interest in the drug, and other relevant outcomes. METHODS: An online experiment was conducted using a 1 × 3 between-subjects design to compare three different framing statements, which was replicated across three different DTC television ads that focused on different medical conditions (arthritis, lung cancer, and type 2 diabetes). A sample of US adults (N = 1961) was randomly assigned to view one of nine television ads and asked to respond to a questionnaire. RESULTS: The type of framing statement had significant effects on perceived risk severity, perceived utility of risk and benefit information, fear of risks, and perceived likelihood of explicit and implicit benefits. CONCLUSIONS: Consumers pay attention to and use cues to process and interpret the risk information presented to them in DTC television ads. Using lead-in language that describes risk severity, particularly for products with severe, life-threatening risks, may better allow consumers to make evaluative judgments on risk severity in DTC ads than stating the drug can cause serious reactions or simply that reactions are possible. More work is needed to examine the factors that affect people's understanding of the nature of risk severity, particularly with regard to risk recognition. Published by Elsevier Inc.
RCT Entities:
BACKGROUND: Research on the major risk statement in direct-to-consumer (DTC) prescription drug television ads has shown that risk severity and actionability can affect consumers' risk comprehension and perceptions. A framing statement presented just before the major risk statement may serve as a cue that directs attention to the risk statement that follows, or it may guide consumers' interpretation of the severity of the risks that follow. OBJECTIVE: Examine how the use of different framing statements (severe, life-threatening; serious; or basic) that precede the major risk statement in DTC television ads affect consumers' risk perceptions, risk recognition, benefit perceptions, interest in the drug, and other relevant outcomes. METHODS: An online experiment was conducted using a 1 × 3 between-subjects design to compare three different framing statements, which was replicated across three different DTC television ads that focused on different medical conditions (arthritis, lung cancer, and type 2 diabetes). A sample of US adults (N = 1961) was randomly assigned to view one of nine television ads and asked to respond to a questionnaire. RESULTS: The type of framing statement had significant effects on perceived risk severity, perceived utility of risk and benefit information, fear of risks, and perceived likelihood of explicit and implicit benefits. CONCLUSIONS: Consumers pay attention to and use cues to process and interpret the risk information presented to them in DTC television ads. Using lead-in language that describes risk severity, particularly for products with severe, life-threatening risks, may better allow consumers to make evaluative judgments on risk severity in DTC ads than stating the drug can cause serious reactions or simply that reactions are possible. More work is needed to examine the factors that affect people's understanding of the nature of risk severity, particularly with regard to risk recognition. Published by Elsevier Inc.
Entities:
Keywords:
Adverse effects; Direct-to-consumer prescription drug advertising; Message framing; Prescription drug; Risk perception; Signaling theory
Authors: Christine Lee; Melanie J McLean; Caroline J Huang; Anh Nguyen Zarndt; Kathryn J Aikin; Paula Rausch; Barbara R Cohen; Janine Delahanty; Danielle M Sholly; Wendy I Slavit; Ewa D Carlton Journal: J Prim Care Community Health Date: 2021 Jan-Dec
Authors: Kristen Giombi; Catherine Viator; Juliana Hoover; Janice Tzeng; Helen W Sullivan; Amie C O'Donoghue; Brian G Southwell; Leila C Kahwati Journal: PLoS One Date: 2022-02-03 Impact factor: 3.240